2016 July

Federal Laboratory Consortium Recognizes Unituxin Collaborators with Excellence in Technology Transfer Awards

The Federal Laboratory Consortium (FLC) presented an Excellence in Technology Transfer award to the group that collaborated to bring Unituxin (dinutuximab, also known as ch14.18), an immunotherapy for neuroblastoma, to licensure.

Tags: 

Pages

Subscribe to 2016 July